Fc-receptors as regulators of immunity

被引:297
作者
Nimmerjahn, Falk [1 ,2 ]
Ravetch, Jeffrey V. [2 ]
机构
[1] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Lab Expt Immunol & Immunotherapy, D-91054 Erlangen, Germany
[2] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA
来源
ADVANCES IN IMMUNOLOGY, VOL 96 | 2007年 / 96卷
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0065-2776(07)96005-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Receptors for immunoglobulins [Fc-receptors (FcRs)] are widely expressed throughout the immune system. By binding to the antibody Fc-portion, they provide a link between the specificity of the adaptive immune system and the powerful effector functions triggered by innate immune effector cells. By virtue of coexpression of activating and inhibitory FcRs on the same cell, they set a threshold for immune cell activation by immune complexes (ICs). Besides their involvement in the efferent phase of an immune response, they are also important for modulating adaptive immune responses by regulating B cell and dendritic cell (DC) activation. Deletion of the inhibitory FcR leads to the loss of tolerance in the humoral immune system and the development of autoimmune disease. Uptake of ICs by FcRs on DCs and the concommitant triggering of activating and inhibitory signaling pathways will determine the strength of the initiated T-cell response. Loss of this balanced signaling results in uncontrolled responses that can lead to the damage of healthy tissues and ultimately to the initiation of autoimmune processes. in this chapter, we wilt discuss how coexpression of different activating and inhibitory receptors on different immune cells of the innate and adaptive immune system modulates cell activity. Moreover, we will focus on exogenous factors that can influence the balanced triggering of activating and inhibitory FcRs, such as the cytokine milieu and the rote of differential antibody glycosytation.
引用
收藏
页码:179 / 204
页数:26
相关论文
共 129 条
[1]   ISOLATION AND EXPRESSION OF FUNCTIONAL HIGH-AFFINITY FC RECEPTOR COMPLEMENTARY DNAS [J].
ALLEN, JM ;
SEED, B .
SCIENCE, 1989, 243 (4889) :378-381
[2]   The impact of glycosylation on the biological function and structure of human immunoglobulins [J].
Arnold, James N. ;
Wormald, Mark R. ;
Sim, Robert B. ;
Rudd, Pauline M. ;
Dwek, Raymond A. .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :21-50
[3]   Mannan binding lectin and its interaction with immunoglobulins in health and in disease [J].
Arnold, James N. ;
Dwek, Raymond A. ;
Rudd, Pauline M. ;
Sim, Robert B. .
IMMUNOLOGY LETTERS, 2006, 106 (02) :103-110
[4]  
AZEREDO DS, 2002, J EXP MED, V195, P665
[5]   Fc-γRI-deficient mice show multiple alterations to inflammatory and immune responses [J].
Barnes, N ;
Gavin, AL ;
Tan, PS ;
Mottram, P ;
Koentgen, F ;
Hogarth, PM .
IMMUNITY, 2002, 16 (03) :379-389
[6]   Intravenous immunoglobulin in autoimmune disorders: An insight into the immunoregulatory mechanisms [J].
Bayry, J ;
Dasgupta, S ;
Misra, N ;
Ephrem, A ;
Van Huyen, JPD ;
Delignat, S ;
Hassan, G ;
Caligiuri, G ;
Nicoletti, A ;
Lacroix-Desmazes, S ;
Kazatchkine, MD ;
Kaveri, S .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (04) :528-534
[7]   Cell surface recycling of internalized antigen permits dendritic cell priming of B cells [J].
Bergtold, A ;
Desai, DD ;
Gavhane, A ;
Clyne, R .
IMMUNITY, 2005, 23 (05) :503-514
[8]   Direct targeting of genetically modified tumour cells to FcγRI triggers potent tumour cytotoxicity [J].
Bevaart, L ;
Goldstein, J ;
Vitale, LS ;
Russoniello, C ;
Treml, J ;
Zhang, J ;
Graziano, RF ;
Leusen, JHW ;
van de Winkel, JGJ ;
Keler, T .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (03) :317-325
[9]   Decreased transcription of the human FCGR2B gene mediated by the-343 G/C promoter polymorphism and association with systemic lupus erythematosus [J].
Blank, MC ;
Stefanescu, RN ;
Masuda, E ;
Marti, F ;
King, PD ;
Redecha, PB ;
Wurzburger, RJ ;
Peterson, MGE ;
Tanaka, S ;
Pricop, L .
HUMAN GENETICS, 2005, 117 (2-3) :220-227
[10]   Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis [J].
Bolland, S ;
Ravetch, JV .
IMMUNITY, 2000, 13 (02) :277-285